Growth Hormone Deficiency in Mild Traumatic Brain Injury

Clinical trial NCT05660356 · UNKNOWN

Trial details

NCT number: NCT05660356
Sponsor: University of Calgary
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Growth Hormone Treatment Growth Hormone Deficiency Concussion, Mild Concussion Post Syndrome

Start date: 2023-02-01
Primary completion: 2024-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.